Sunkonkit Kanokkarn, Hurvitz Manju, Defante Andrew, Orr Jeremy, Chakraborty Abhishek, Amin Reshma, Bhattacharjee Rakesh
Division of Respiratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sleep Breath. 2025 Jan 7;29(1):68. doi: 10.1007/s11325-024-03183-1.
Reduced forced vital capacity (FVC) is associated with morbidity and mortality in individuals with Duchenne muscular dystrophy (DMD). Non-invasive ventilation (NIV) is often prescribed for the treatment of sleep-disordered breathing (SDB), and chronic respiratory insufficiency. Despite the common practice of initiating NIV later in the progression of DMD, the factors influencing FVC subsequent to the commencement of NIV remain unclear.
To evaluate the demographic, clinical and socioeconomic determinants of FVC% predicted across several cohorts of DMD children and adults prescribed NIV.
A multicenter retrospective review of individuals with DMD prescribed NIV was performed between February 2016 to October 2020. Patients were identified from three sites: The Hospital for Sick Children, Canada; Rady Children's Hospital San Diego, USA; and University of California San Diego Health, USA. Multivariate regression analysis was performed to determine factors that influence FVC.
Fifty-nine male patients with DMD prescribed NIV (mean ± SD for age and BMI was 20.1 ± 6.7 years and 23.8 ± 8.8 kg/m) were included. Following multivariate analysis, a lower FVC% predicted was associated with older age (β = -1.44, p = 0.001), presence of scoliosis (β = -16.94, p = 0.002), absent deflazacort prescription (β = 14.43, p = 0.009), and use of in-ex sufflator (β = -39.73, p < 0.001), respectively.
In our study, several factors were associated with reduced FVC% predicted in a DMD population using NIV. Future, prospective, longitudinal studies are imperative to comprehend the trajectory of FVC% predicted over time in individuals with DMD using NIV.
在杜氏肌营养不良症(DMD)患者中,用力肺活量(FVC)降低与发病率和死亡率相关。无创通气(NIV)常用于治疗睡眠呼吸紊乱(SDB)和慢性呼吸功能不全。尽管在DMD病程后期开始使用NIV很常见,但NIV开始后影响FVC的因素仍不清楚。
评估多个接受NIV治疗的DMD儿童和成人队列中预测FVC%的人口统计学、临床和社会经济决定因素。
对2016年2月至2020年10月期间接受NIV治疗的DMD患者进行多中心回顾性研究。患者来自三个地点:加拿大多伦多病童医院;美国圣地亚哥拉迪儿童医院;以及美国加利福尼亚大学圣地亚哥分校健康中心。进行多变量回归分析以确定影响FVC的因素。
纳入了59例接受NIV治疗的男性DMD患者(年龄和体重指数的平均值±标准差分别为20.1±6.7岁和23.8±8.8kg/m²)。多变量分析后,预测的FVC%较低与年龄较大(β=-1.44,p=0.001)、脊柱侧弯的存在(β=-16.94,p=0.002)、未使用去氟可特处方(β=14.43,p=0.009)以及使用吸气-呼气同步呼吸机(β=-39.73,p<0.001)相关。
在我们的研究中,多个因素与使用NIV的DMD人群中预测的FVC%降低相关。未来需要进行前瞻性纵向研究,以了解使用NIV的DMD患者随时间推移预测的FVC%轨迹。